catechin has been researched along with HPV Infection in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Gnanagurusamy, J; Krishnamoorthy, S; Muruganatham, B; Muthusami, S; Sabanayagam, R | 1 |
| Aarthy, M; Panwar, U; Singh, SK | 1 |
| Balick, M; Castellanos, MR; DeVoti, JA; Einbond, LS; Mbazor, E; Redenti, S; Song, G; Wu, HA; Zhou, J | 1 |
| Alvarado, A; Barros, L; Bastos, MMSM; Borges, I; Félix, L; Ferreira, ICFR; Ferreira, T; Gaivão, I; Gama, A; Lanzarin, G; M Gil da Costa, R; Macedo, S; Medeiros, R; Nascimento-Gonçalves, E; Neuparth, MJ; Nogueira, A; Oliveira, PA; Pires, MJ; Rosa, E; Venâncio, C | 1 |
| Ballesteros, J; Calzavara-Pinton, P; Hercogová, J; Lynde, CW; Rotaru, M; Schöfer, H; Skerlev, M; Tatti, S | 1 |
| Chu, YW; Huang, SM; Liu, ST; Wang, WM; Yang, YL | 1 |
| Atwi, D; Banerjee, P; Fried, A; Hussaini, R; Mukherjee, S; Pan, Q; Piao, L; Sampat, S; White, R | 1 |
| Bilenchi, R; Campoli, M; Cinotti, E; Fimiani, M; Rubegni, P; Trovato, E | 1 |
| Feliciani, C; Gandolfi, M; Milani, M; Rovesti, M; Satolli, F; Zucchi, A | 1 |
| Alberts, DS; Byron, JW; Chow, HH; Cornelison, T; Garcia, FA; Greenspan, DL; Hsu, CH; Nuño, T | 1 |
| Doan, HQ; Nguyen, HP; Rady, P; Tyring, SK | 1 |
| Chow, HH; Feugang, JM; Garcia, F; Hao, Z; Liu, H; Zou, C | 1 |
| Butler, LM; Wu, AH | 1 |
| Datta, SD; Dunne, EF; Friedman, A; Markowitz, LE; Workowski, KA | 1 |
| Meyer, T; Stockfleth, E | 1 |
| Gormley, RH; Kovarik, CL | 1 |
| Rosen, T | 1 |
| Ahn, WS; Bae, SM; Huh, SW; Kim, CK; Lee, IP; Lee, JM; Namkoong, SE; Yoo, J | 1 |
| Beti, H; Grigorian, F; Mescheder, A; Orasan, R; Stockfleth, E; Tawfik, H; Thielert, C | 1 |
5 review(s) available for catechin and HPV Infection
| Article | Year |
|---|---|
Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Catechin; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Male; Papillomavirus Infections; Plant Extracts; Tea; Treatment Outcome | 2017 |
Green and black tea in relation to gynecologic cancers.
Topics: Alphapapillomavirus; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antiviral Agents; Camellia sinensis; Catechin; Condylomata Acuminata; Endometrial Neoplasms; Female; Humans; Immunologic Factors; Ovarian Neoplasms; Papillomavirus Infections; Plant Leaves; Precancerous Conditions; Risk; Species Specificity; Tea; Uterine Cervical Neoplasms | 2011 |
The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts.
Topics: Administration, Cutaneous; Animals; Antiviral Agents; Catechin; Chemistry, Pharmaceutical; Condylomata Acuminata; Human papillomavirus 11; Human papillomavirus 6; Humans; Ointments; Papillomavirus Infections; Recurrence; Treatment Outcome | 2012 |
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts | 2012 |
Green tea catechins: biologic properties, proposed mechanisms of action, and clinical implications.
Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Catechin; Cell Proliferation; Condylomata Acuminata; Humans; Papillomavirus Infections; Plant Extracts; Plant Leaves; Tea | 2012 |
3 trial(s) available for catechin and HPV Infection
| Article | Year |
|---|---|
Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia.
Topics: Adolescent; Adult; Catechin; Double-Blind Method; Female; Humans; Middle Aged; Papillomavirus Infections; Placebo Effect; Tea; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2014 |
Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions.
Topics: Administration, Oral; Administration, Topical; Adult; Antineoplastic Agents, Phytogenic; Catechin; Female; Humans; Papillomaviridae; Papillomavirus Infections; Tea; Urokinase-Type Plasminogen Activator; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Uterine Cervicitis | 2003 |
Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Catechin; Condylomata Acuminata; Dose-Response Relationship, Drug; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Middle Aged; Papillomavirus Infections; Phytotherapy; Plant Preparations; Treatment Outcome | 2008 |
11 other study(ies) available for catechin and HPV Infection
| Article | Year |
|---|---|
EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells.
Topics: Catechin; Epidermal Growth Factor; Female; Humans; Matrix Metalloproteinase 2; Papillomavirus Infections; Tumor Microenvironment; Uterine Cervical Neoplasms | 2023 |
Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7.
Topics: Antiviral Agents; Catechin; Cell Proliferation; Chemoprevention; Drug Discovery; Drug Evaluation, Preclinical; Female; High-Throughput Screening Assays; Human papillomavirus 16; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Papillomavirus E7 Proteins; Papillomavirus Infections; Principal Component Analysis; Protein Conformation; Uterine Cervical Neoplasms; Virus Internalization | 2020 |
A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Proliferation; Curcumin; DNA, Viral; Female; Human papillomavirus 16; Humans; Papillomavirus Infections; Resveratrol; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2021 |
Toxicological and anti-tumor effects of a linden extract (
Topics: Animals; Antineoplastic Agents; Catechin; Epidermis; Female; Flavonoids; Human papillomavirus 16; Hydroxybenzoates; Kidney; Liver; Male; Mice; Mice, Transgenic; Papillomavirus Infections; Plant Extracts; Tilia | 2021 |
The cytotoxic mechanism of epigallocatechin gallate on proliferative HaCaT keratinocytes.
Topics: Antineoplastic Agents; Catechin; Cell Line; Cells, Cultured; Condylomata Acuminata; Humans; Papillomaviridae; Papillomavirus Infections | 2017 |
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Catechin; Curcumin; Female; Head and Neck Neoplasms; Humans; Killer Cells, Natural; Lung Neoplasms; Macrophages; Mice; Mice, Inbred C57BL; Mice, Nude; Papillomaviridae; Papillomavirus Infections; Resveratrol; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Sinecatechins 10% ointment for genital warts: Case report of a beneficial reaction in an HIV-positive woman.
Topics: Adult; Catechin; Condylomata Acuminata; Dermatologic Agents; Female; HIV Infections; HIV Seropositivity; Human papillomavirus 6; Humans; Ointments; Papillomavirus Infections; Real-Time Polymerase Chain Reaction; Treatment Outcome | 2018 |
Generalized verrucosis: A therapeutic challenge: Efficacy of topical sinecatechins (Veregen) 10.
Topics: Administration, Cutaneous; Antiviral Agents; Catechin; Female; Humans; Middle Aged; Papillomavirus Infections; Treatment Outcome; Warts | 2019 |
Expression patterns of immune-associated genes in external genital and perianal warts treated with sinecatechins.
Topics: Administration, Topical; Anus Diseases; Catechin; Condylomata Acuminata; Female; Gene Expression Profiling; Humans; Immune System; Immunologic Factors; Male; Microarray Analysis; Papillomavirus Infections; Prospective Studies | 2015 |
Green tea compound in chemoprevention of cervical cancer.
Topics: Apoptosis; Blotting, Western; Catechin; Cell Cycle; Cell Proliferation; Cells, Cultured; Cervix Uteri; Female; Human papillomavirus 16; Humans; Immunoenzyme Techniques; Papillomavirus E7 Proteins; Papillomavirus Infections; Tea; Uterine Cervical Neoplasms | 2010 |
Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.
Topics: Anti-Infective Agents, Local; Antiviral Agents; Catechin; Condylomata Acuminata; Counseling; Female; Humans; Male; Papillomavirus Infections; Papillomavirus Vaccines; Practice Guidelines as Topic; United States; Uterine Cervical Neoplasms | 2011 |